TD Cowen issued a buy rating and price target for Edwards Lifesciences, while Royal Bank of Canada reiterated its 'outperform' rating on the stock.
1 report, 1 independent
Updated Jun 16
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
TD Cowen issued a buy rating and price target for Edwards Lifesciences, while Royal Bank of Canada reiterated its 'outperform' rating on the stock.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
TD Cowen
American investment bank
-
Edwards Lifesciences
American medical technology company
-
Royal Bank of Canada
financial institution in Canada
Related events
- Truist Financial set a $90.00 price target on Edwards Lifesciences shares, and TD Cowen reaffirmed its buy rating and raised the price objective.
- TD Cowen raised its price target and issued a buy rating for Globe Life.
- TD Cowen lifted its price target and gave a buy rating for Hilton Worldwide.
- TD Cowen and Bank of America issued buy ratings and increased price targets on November 2, 2026.
- TD Cowen decreased its target price and set a hold rating for Honeywell Aerospace, with MarketBeat reporting the average stock rating.